Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131623 · ClinicalTrials.gov registry record
Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease
A clinical trial, sponsored by Mirum Pharmaceuticals.
- Completed
- Registry status
- 23
- Enrollment target
NCT02131623 is a clinical trial that has completed, run by Mirum Pharmaceuticals. The registered enrollment target is 23 participants.
The verdict
NCT02131623 has completed, sponsored by Mirum Pharmaceuticals.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of the study is to validate the ItchRO instrument (a clinical outcome assessment measure of itching) prior to the analysis of longitudinal treatment effect data being generated in ongoing clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02131623
The ClinicalTrials.gov registry entry for NCT02131623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mirum Pharmaceuticals, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02131623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02131623 about?
NCT02131623 is a clinical study titled "Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease". The purpose of the study is to validate the ItchRO instrument (a clinical outcome assessment measure of itching) prior to the analysis of longitudinal treatment effect data being generated in ongoing clinical trials.
What is the current status of trial NCT02131623?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2014-07. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02131623?
This trial is sponsored by Mirum Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.